Bridges Investment Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Bridges Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $1.02 Million - $1.41 Million	-3,739 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $117,314 - $136,589	429 Added 12.96%	3,739 $1.04 Million
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $32,956 - $45,630	110 Added 3.44%	3,310 $1.04 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $622,946 - $747,639	1,855 Added 137.92%	3,200 $1.2 Million
Q3 2018 Nov 15, 2018	BUY	$351.14 - $408.51 $472,283 - $549,445	1,345 New	1,345 $543,000

1,531

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Bridges Investment Management Inc with notifications on news.